Postoperative Biliary Fistula Prevention After Hepatectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

304 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2017-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim : Effect of external biliary duct stent after hepatectomy on the occurence of postoperative biliary fistula.

Methods : French prospective multicenter randomized trial. Population study: Adult patients who underwent hepatectomy (\> 2 segments) on non-cirrhotic liver.

Hypothesis: decreased postoperative biliary fistula from 15% to 5% with the presence of a external biliary duct stent. With this hypothesis, the number of patients required to be equal to 152 per group for a total of 304 patients.

Outcome measure: Primary : Postoperative biliary complications (biliary fistula, biloma, biliary peritonitis) Secondary : All morbidity, mortality, additional manoeuvres to treat biliary fistula, during of hospital stay and biliary fistula.

Follow up: A follow-up of patients 3 months after surgery for all patients. The planned total duration of the study is 3 years and 3 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy

NCT01847612

Liver Disease

COMPLETED PHASE3

Gallbladder Stenting in FC-SEMS

NCT06820541

Biliary Obstruction Acute Cholecystitis

NOT_YET_RECRUITING NA

External Pancreatic Duct Stent After Pancreaticoduodenectomy

NCT01068886

Pancreatic Fistula

COMPLETED PHASE3

Biliary Externalization After Pancreaticoduodenectomy

NCT04654299

Postoperative Complications

COMPLETED

Placement of Biliary Drainage Stent to Prevent Biliary Intestinal Anastomosis After Liver Transplantation in Children

NCT06048445

Liver Transplant; Complications

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After performing the hepatectomy and verification of hemostasis, patients were randomized (external biliary duct stent or not) by sealed envelopes. Systematic intraoperative test with methylene blue or air by the external biliary duct stent (EBDS) will necessary for all patients. Intra-abdominal drainage or not and type will be at the discretion of the surgeon. The EBDS will be left open for the first 7 postoperative days and then clamped. The EBDS will be removed during a consultation 5 weeks after surgery. Both groups of patients will be reviewed at 3 months after surgery, it will be noted at this point the possible complications related to the presence of EBDS (leakage from the drain, drop..). If patients are hospitalized more than five weeks, the study will stop at their consultation three months or the day of the consultation where the DTC is removed if it is still present at 3 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

external biliary duct stent

'External Biliary duct stent in the bile duct by cystic way'

Group Type EXPERIMENTAL

External Biliary duct stent in the bile duct by cystic way

Intervention Type PROCEDURE

The size of the external biliary duct stent depending of cystic duct size

without external biliary duct stent

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

External Biliary duct stent in the bile duct by cystic way

The size of the external biliary duct stent depending of cystic duct size

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has given his informed consent and signed consent
* Hepatectomy at least 2 segments of liver parenchyma for a benign or malignant disease by laparotomy
* Not cirrhotic liver

Exclusion Criteria

* Surgery made in emergency
* Surgery by laparoscopy
* Need to draw up a bilic-digestive anastomosis
* Liver cirrhosis
* History of cholecystectomy
* Resection of less than 2 segments
* Preoperative jaundice (total bilirubin\> 30 micromol / l)
* Presence of preoperative biliary drainage
* Patients requiring the installation of a drain transcystic during the operation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No